1. Home
  2. PUBM vs MRVI Comparison

PUBM vs MRVI Comparison

Compare PUBM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PubMatic Inc.

PUBM

PubMatic Inc.

HOLD

Current Price

$8.56

Market Cap

416.8M

Sector

Technology

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.85

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUBM
MRVI
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.8M
449.6M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PUBM
MRVI
Price
$8.56
$3.85
Analyst Decision
Buy
Buy
Analyst Count
10
7
Target Price
$18.45
$4.57
AVG Volume (30 Days)
490.4K
1.3M
Earning Date
02-26-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$288,382,000.00
$192,435,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.49
$9.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.01
$1.67
52 Week High
$17.32
$6.21

Technical Indicators

Market Signals
Indicator
PUBM
MRVI
Relative Strength Index (RSI) 41.86 61.96
Support Level $8.46 $3.19
Resistance Level $8.90 $4.02
Average True Range (ATR) 0.28 0.17
MACD -0.05 0.05
Stochastic Oscillator 9.20 78.18

Price Performance

Historical Comparison
PUBM
MRVI

About PUBM PubMatic Inc.

PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: